About Resilience
Resilience is a company based in San Diego (United States) founded in 1995. It operates as a Professional Services and Managed Services. Resilience has raised $1.99 billion across 11 funding rounds from investors including HHS, Mubadala and Arch Venture Partners. Resilience has completed 2 acquisitions, including Ology Bio and Swift Scale Bio. Resilience offers products and services including Sprout Solutions™, DAR-T™, Essential AAV & LVV, and Idea to Clinic™. Resilience operates in a competitive market with competitors including McKesson, Entero Healthcare, BioAscent, Zhejiang Mingdu Zhikong Technology and Take Solutions, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name National Resilience, Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Resilience
Resilience offers a comprehensive portfolio of products and services, including Sprout Solutions™, DAR-T™, Essential AAV & LVV, and Idea to Clinic™.
Drug substance and fill/finish are supported with transparency.
Autologous CAR-T manufacturing is completed in three days.
Viral vector batches are produced within twelve months.
Biologic development to clinic is accelerated by 30%.
People of Resilience
Unlock access to complete
Unlock access to complete
Funding Insights of Resilience
Resilience has successfully raised a total of $1.99B across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $825 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Resilience
Resilience has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Mubadala and Arch Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency supporting the development of SMEs
|
Locked | Locked | Locked | |
|
Venture capital firm focused on life science companies
|
Locked | Locked | Locked | |
|
Venture capital firm investing in technology, life sciences, and related sectors.
|
Locked | Locked | Locked |
Investor details for Resilience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Resilience
Resilience has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Ology Bio and Swift Scale Bio.
Investment portfolio details for Resilience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Cell-free protein synthesis platform for antibody treatments is developed.
|
Locked | Locked | 2019 | Locked | |
|
Biologics-focused contract development and manufacturing organization (CDMO)
|
Locked | Locked | 1999 | Locked |
Complete acquisition details for Resilience
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Resilience
Detailed financials for Resilience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Resilience Comparisons
Peer comparison for Resilience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Resilience
Resilience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as McKesson, Entero Healthcare, BioAscent, Zhejiang Mingdu Zhikong Technology and Take Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products and services are provided in the healthcare industry.
|
|
| Locked | Locked | Locked |
India's leading healthcare products distribution platform
|
|
| Locked | Locked | Locked |
Compound management solutions are offered for drug discovery processes.
|
|
| Locked | Locked | Locked |
AI-based logistics services are provided in Hangzhou, China.
|
|
| Locked | Locked | Locked |
Life sciences and supply chain management services are provided.
|
Detailed competitors of Resilience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Resilience
Complete news archive for Resilience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Resilience
Resilience was founded in 1995 and raised its 1st funding round 11 years after it was founded.
Resilience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Rahul Singhvi is the current CEO of Resilience.
Resilience is a funded company, having raised a total of $1.99B across 11 funding rounds to date.
Resilience is established as a contract development and manufacturing organization (CDMO) specializing in biologics, cell therapy, and gene therapy. Services are provided across various sectors including vaccines, viral vectors, and nucleic acids. End-to-end solutions are offered for development, scale-up, and tech transfer, ensuring speed and flexibility. Facilities are located throughout North America, supporting global markets in the EU, Asia, and the Middle East. Innovation is driven through partnerships and advanced technologies to enhance access to complex medicines.
Resilience's top competitors include Entero Healthcare, McKesson and ASP Isotopes.
Resilience offers Sprout Solutions™, DAR-T™, Essential AAV & LVV, and Idea to Clinic™.
Resilience has made 2 acquisitions, including Ology Bio, and Swift Scale Bio.
Resilience has 12 investors. Key investors include HHS, Mubadala, Arch Venture Partners, Kennet Partners, and DFC.